|
Who Should Register
This workshop is designed for scientists and consumer advocates who have an interest in new approaches to developing or enhancing agents or combinations of agents for the diagnosis, treatment or prevention of cancer. Individuals with limited experience in the regulatory aspects of oncology drug development will benefit from this Workshop.
Workshop Participant Criteria
- Industry:Registrants should be involved in drug development.
- Government: Registrants should be a employed by a U.S. government agency involved in oncology research and drug development.
- Academic: Previous or current clinical trial experience. NOTE: A limited number of senior Fellows will be admitted. Fellows should be nearing the formal completion of their training. A letter of endorsement from applicant's department head or division chief must accompany the registration.
- Advocates: Consumer and/or patient advocates should be sponsored by a nationally recognized advocacy organization or foundation. Advocates should have a background in clinical trial design and the role of the advocate in the development process. A letter of endorsement from an official of the sponsoring organization must accompany the registration.
The number of Workshop participants will be limited, therefore early enrollment is encouraged. Registration will be closed when the course capacity has been reached.
|
